Patients with rare, incurable digestive tract cancers respond to new drug combination
Patients with rare, but incurable cancers of the digestive tract have responded well to a…
Browsing: 30th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Drug designed to boost radiotherapy for hard to treat cancers taken safely by patients
A new drug designed to make radiotherapy more effective in treating cancer has been given…
Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
An antibody that binds simultaneously to two distinct regions of the HER2 receptor to block…